Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing Lu

Showing results (931-940 of 938) with videos related to

Pageof 94
Sort By:
You have reached the last page of results.This site can display upto 938 results.
Investigational New Drugs|November 15, 2017
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancerXuenong Ouyang, Meiqi Shi, Fangwei Jie, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Acta Pharmacologica Sinica|July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture riskHao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric ModulatorMichael T Rudd, Peter J Manley, Barbara Hanney, et al.
Translational Lung Cancer Research|October 17, 2022
International consensus on radiotherapy in metastatic non-small cell lung cancerZhengfei Zhu, Jianjiao Ni, Xuwei Cai, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|May 14, 2015
Genetic diversity and evolutionary dynamics of Ebola virus in Sierra LeoneYi-Gang Tong, Wei-Feng Shi, Di Liu, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 94

Showing results (931-940 of 938) with videos related to

Sort By:
Pageof 94
You have reached the last page of results.This site can display upto 938 results.
Investigational New Drugs|November 15, 2017
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancerXuenong Ouyang, Meiqi Shi, Fangwei Jie, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Acta Pharmacologica Sinica|July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture riskHao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric ModulatorMichael T Rudd, Peter J Manley, Barbara Hanney, et al.
Translational Lung Cancer Research|October 17, 2022
International consensus on radiotherapy in metastatic non-small cell lung cancerZhengfei Zhu, Jianjiao Ni, Xuwei Cai, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|May 14, 2015
Genetic diversity and evolutionary dynamics of Ebola virus in Sierra LeoneYi-Gang Tong, Wei-Feng Shi, Di Liu, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 94